CREDIT SUISSE AG/ - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 128 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,273,278
-17.7%
163,871
+2.6%
0.00%
-50.0%
Q2 2023$1,546,768
+13.0%
159,790
+28.0%
0.00%
+100.0%
Q1 2023$1,368,312
+172.4%
124,846
+7.4%
0.00%0.0%
Q4 2022$502,269
-52.7%
116,266
-17.6%
0.00%0.0%
Q3 2022$1,061,000
+11.3%
141,089
+48.9%
0.00%0.0%
Q2 2022$953,000
-26.1%
94,761
-9.0%
0.00%0.0%
Q1 2022$1,289,000
-80.0%
104,099
-63.0%
0.00%
-66.7%
Q4 2021$6,429,000
+254.4%
281,147
+243.1%
0.00%
+200.0%
Q3 2021$1,814,000
+42.9%
81,947
-16.4%
0.00%0.0%
Q2 2021$1,269,000
-41.2%
97,975
-41.0%
0.00%0.0%
Q1 2021$2,157,000
+35.6%
166,083
+44.4%
0.00%0.0%
Q4 2020$1,591,000
+11.2%
114,978
+18.4%
0.00%0.0%
Q3 2020$1,431,000
+33.4%
97,086
+47.0%
0.00%0.0%
Q2 2020$1,073,000
+5.4%
66,027
-5.8%
0.00%0.0%
Q1 2020$1,018,000
+1.8%
70,092
+42.0%
0.00%0.0%
Q4 2019$1,000,000
+726.4%
49,358
+116.4%
0.00%
Q3 2019$121,000
-24.4%
22,806
-6.2%
0.00%
Q2 2019$160,000
+23.1%
24,303
+20.9%
0.00%
Q1 2019$130,000
+10.2%
20,109
+16.8%
0.00%
Q4 2018$118,000
-7.1%
17,215
-9.5%
0.00%
Q3 2018$127,000
-0.8%
19,027
-16.8%
0.00%
Q2 2018$128,000
-12.9%
22,878
-19.2%
0.00%
Q1 2018$147,000
+69.0%
28,300
+46.8%
0.00%
Q4 2017$87,00019,2790.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders